04/29/2016 - 12:02pm

The states with the highest rates of influenza, according to the Index, were Arizona, Texas, Kentucky, Mississippi and Tennessee.

04/27/2016 - 12:07pm

 On Tuesday, the FDA approved Aurobindo’s generic Exforge (amlodipine and valsartan) tablets, and on Wednesday gave its OK to the company’s generic Opana (oxymorphone HCl) and Pepcid AC (famotidine). 

04/26/2016 - 12:15pm

A new partnership between the two companies will see development and commercialization of generics with a high technological barrier. 

04/26/2016 - 10:07am

The researchers are currently conducting a National Health and Medical Research Council study using a combination of these nutraceuticals for depression.

04/25/2016 - 11:53am

The drug had an estimated market size of about $4.2 billion for the 12 months ending February 2016, according to IMS Health. 

04/25/2016 - 9:05am

Perrigo's new CEO led the company's U.S. Consumer Healthcare business from 2003 to 2006

04/22/2016 - 12:27pm
The drug had U.S. sales of about $39 million for the 12 months ended December 2015, according to IMS Health. 
04/15/2016 - 6:34pm

A new bill looks to push the FDA into rewriting a guidance on generic drug and biosimilar naming by withholding funding unless it meets Congress’ requests. 

04/14/2016 - 12:40pm

In 2015, the OGD granted 580 approvals and 146 tentative approvals, including 99 in December alone – the largest number of drug approvals given out in a single month.